Announcement
03 Jul 2020
In July 2020, the Norwegian authorities introduced an export ban on formoterol and budesonide following the outbreak of COVID-19. In July 2020, the export ban was terminated.
Source
Sign in to access
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
List of interventions
Implementation date
03 Jul 2020
Revocation date:
13 Jul 2020
Updated: 03 Jul 2020
Export ban
On 3 July 2020, the Norwegian Medicines Agency introduced an export ban on formoterol and budesonide. The export ban was introduced due to concerns of shortages following the ou...
Sign in to see more
Related State Acts
14 Jul 2020
Norway: Introduction of export notification requirement on formoterol and budesonide (COVID-19)
15 Jun 2020
Norway: Introduction of export notification requirement on several pharmaceutical goods (COVID-19)
20 May 2020
Norway: Introduction and subsequent termination of export ban on formoterol, glycopyrronium bromide and beclomethasone following the outbreak of COVID-19
21 Apr 2020
Norway: Introduction of export notification requirement on medications for treating obstructive pulmonary diseases following the COVID-19 outbreak
Threads
See all
This state act is not part of any Thread yet.